Will Shire's acute HAE drug OK shift dynamic for ViroPharma's prophylactic?
26 August 2011
Donna Young
Please Login to read the full article.
26 August 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA panel backs Shire's Firazyr as self-administered acute HAE treatment
- US FDA declares Shire's Firazyr effective, safe for HAE ahead of panel
- ViroPharma's Cinryze granted European approval for hereditary HAE
- Promising Phase II subcutaneous Cinryze data in HAE to inform further trial design
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
